Ciprofloxacin once versus twice daily in the treatment of complicated urinary tract infections

International Journal of Antimicrobial Agents

Volumn 11, Issue 2, 1999, Pages 133-138

  Krcmery, S ^a   Naber, K G ^a  

^a Urologische Klinik   (Germany)

Author keywords

Ciprofloxacin; Complicated urinary tract infections

Indexed keywords

CIPROFLOXACIN;

ADULT; ARTICLE; BACTERIURIA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DRUG EFFICACY; DRUG SAFETY; ENTEROBACTERIACEAE; ENTEROCOCCUS; ESCHERICHIA COLI; FEMALE; GASTROINTESTINAL DISEASE; HUMAN; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROTEUS MIRABILIS; PSEUDOMONAS; RANDOMIZED CONTROLLED TRIAL; STAPHYLOCOCCUS; SUPERINFECTION; URINARY TRACT INFECTION;

EID: 0032966498     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-8579(98)00088-0     Document Type: Article

References (9)

1. Beam TR, Gilbert DN, Kunin CM, editors. European Guidelines for the Clinical Evaluation of Anti-Infective Drug Products 1993 (with modifications by a European Working Party). European Society of Clinical Microbiology and Infectious Diseases, 1993.
2. Rubin RH, Shapiro ED, Andriole VT, Davis RJ, Stamm WE. Evaluation of new anti-infective drugs for the treatment of urinary tract infections. Clin Infect Dis 1992;15(Suppl.1):216-27.
3. Nicolle LE. A practical guide to the management of complicated urinary tract infections. Drugs 1997;53:583-92.
4. Naber KG. Fluoroquinolones in urinary tract infections - proper and improper use. Drugs 1996;52(Suppl. 2):27-33.
5. Cox CE. Comparative study of three dosage regimens of ciprofloxacin in the treatment of UTI. Proceedings, 1st International Ciprofloxacin Workshop, 1996:291-6.
6. Frankenschmidt A, Naber KG, Bischoff W, Kullmann KH. Once-daily fleroxacin versus twice-daily ciprofloxacin in the treatment of complicated urinary tract infections. J Urol 1997;158:1494-9.
7. Gasser TC, Graversen PH, Madsen PO. Treatment of complicated urinary tract infections with ciprofloxacin. Am J Med 1987;82(Suppl.4A):278-9.
8. Naber KG. Characteristics of patients with urinary tract infections. Infection 1992;20(Suppl. 3): 145-8.
9. Naber KG. Experiment with the new guidelines on evaluation of new anti-infection drugs for the treatment of urinary tract infections. Int J Antimicrob Agents (in press).